Zdrowie i gospodarka · 19/11/1998

FDA Releases Draft Guidance for In Vivo Drug Metabolism Studies

The FDA has published a draft guidance for industry outlining recommendations for conducting in vivo drug metabolism and interaction studies for new drugs and biologics, aiming to improve safety and effectiveness assessments.